Corporations Partner to Facilitate Earlier Diagnosis of Lupus
January 25, 2018
January 25, 2018
KANSAS CITY, Missouri, Jan. 25 -- Kansas City Public Schools issued the following news:
Exagen Diagnostics and GlaxoSmithKiine (GSK) have announced a collaborative effort to raise awareness of Exagen's AVISE laboratory tests which enables physicians to make an earlier diagnosis of lupus and monitor the health status of people undergoing treatment. The Lupus Foundation of America (Foundation) played an important role in the development of these tests. We funded the early research stu . . .
Exagen Diagnostics and GlaxoSmithKiine (GSK) have announced a collaborative effort to raise awareness of Exagen's AVISE laboratory tests which enables physicians to make an earlier diagnosis of lupus and monitor the health status of people undergoing treatment. The Lupus Foundation of America (Foundation) played an important role in the development of these tests. We funded the early research stu . . .